Suchergebnisse - "Bunn, Paul"

PubPharm (390)

1

RESILIENT Part 2 : A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Spigel, D. | Dowlati, A. | Chen, Y. | +115

2

The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC

enthalten in: JTO clinical and research reports | 2024

von Patil, T. | Staley, A. | Nie, Y. | +19

3

Author Correction : Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

enthalten in: Nature medicine | 2024

von Chaft, J. | Oezkan, F. | Kris, M. | +35

ErratumFor: Nat Med. 2022 Oct;28(10):2155-2161. - PMID 36097216

4

Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC : Results From the LCMC3 Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Dacic, S. | Travis, W. | Giltnane, J. | +25

5

Clinical insights into small cell lung cancer : Tumor heterogeneity, diagnosis, therapy, and future directions

enthalten in: CA: a cancer journal for clinicians | 2023

von Megyesfalvi, Z. | Gay, C. | Popper, H. | +14

6

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

enthalten in: Cancer cell | 2023

von Rodilla, A. | Valanparambil, R. | Mack, P. | +19

7

Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjects

enthalten in: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica | 2023

von Jonsson, S. | Franklin, W. | Varella-Garcia, M. | +8

8

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Dacic, S. | Travis, W. | Redman, M. | +41

9

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Hanna, N. | Shepherd, F. | Fossella, F. | +17

RepublishedFrom: J Clin Oncol. 2004 May 1;22(9):1589-97. - PMID 15117980

10

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy : JCO flashback

enthalten in: Journal of clinical oncology | May 17, 2023

von Hanna, N. | Shepherd, F. | Fossella, F. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[39]